Patent · US Active

Serpina1 siRNAs: compositions of matter and methods of treatment

US9879261B2 · kind B2 · utility

9Cited by
1References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 18, 2015
Grant dateJan 30, 2018
Priority date
Expiry dateDec 18, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG03G2215/0888
  • WIPO fieldOptics
  • WIPO sectorInstruments

Abstract

The technology described herein relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the Serpina1 gene, and methods of using such dsRNA compositions to inhibit expression of Serpina1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.